Objective: A patient survey was conducted by questionnaire to evaluate patient acceptance and perceptions of efficacy with zanamivir (Glaxo Wellcome), the first in a new class of neuraminidase ...
Most commonly used drugs don’t reduce symptoms, hospitalizations, or mortality rates for low- and high-risk patients.
A systematic review and meta-analysis led by Shandong University in China has evaluated the comparative efficacy and safety ...